RMX Biopharma
Industry
- Biotechnology
- Pharmaceuticals
See more in Biomedtracker
Latest on RMX Biopharma
Scrip
• By Jung Won Shin and Brian Yang
Open innovation has been the buzzword for the South Korean pharma/biotech industry for some time; now the quest to find partners and tap capital they badly need to conduct clinical trials and advance
Scrip
• By Joseph Haas, Ying Huang, Kevin Grogan, and Jung Won Shin
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal in